| Literature DB >> 20515431 |
Björn E Rosengren1, Henrik G Ahlborg, Per Gärdsell, Ingemar Sernbo, Robin M Daly, Jan-Ake Nilsson, Magnus K Karlsson.
Abstract
BACKGROUND ANDEntities:
Mesh:
Year: 2010 PMID: 20515431 PMCID: PMC2917568 DOI: 10.3109/17453674.2010.492762
Source DB: PubMed Journal: Acta Orthop ISSN: 1745-3674 Impact factor: 3.717
Figure 1.Enrollment and participation of urban and rural women in the study.
Number of participant in the study by age, cohort and measurement and mean age per cohort
| 1988/89 | 1998/99 | |||
|---|---|---|---|---|
| Age | Urban | Rural | Urban | Rural |
| 50 | 63 | 46 | 53 | 40 |
| 60 | 60 | 46 | 41 | 29 |
| 70 | 85 | 53 | 41 | 29 |
| 80 | 49 | 35 | 36 | 20 |
| Total number | 257 | 180 | 171 | 118 |
| Mean age (years) | 65 | 64 | 65 | 62 |
| (95% CI) | (64–67) | (62–66) | (63–66) | (61–64) |
Figure 2.Annual age-adjusted hip fracture incidence between 1987 and 2002 in all women, urban women, and rural women (aged ≥ 50 years), with 95% confidence interval. There were no statistically significant changes in any group.
Primary investigation of the urban and rural female study participants in 1988/89 and 1998/99
| Urban | Rural | |||
|---|---|---|---|---|
| 1988/89 | 1998/99 | 1988/89 | 1998/99 | |
| n = 257 | n = 171 | n = 180 | n = 118 | |
| BMD (mg/cm2) | 446 (436–457) | 450 (435–464) | 460 (447–472) | 471 (453–488) |
| Prevalence of osteoporosis (%) | 15 (11–21) | 17 (11–23) | 10 (6–16) | 11 (6–18) |
| BMI (kg/m2) | 25 (25–26) | 26 (25–27) | 28 (27–28) | 27 (26–27) |
Data are presented as mean (95% CI). Analysis of the women in the same area in 1988–1989 and 1998–1999 showed no significant differences after Bonferroni correction.
Secondary investigation of the urban and rural female study participants in 1988/89 and 1998/99
| Urban | Rural | |||
|---|---|---|---|---|
| 1988/89 | 1998/99 | 1988/89 | 1998/99 | |
| n = 257 | n = 171 | n = 180 | n = 118 | |
| Height (cm) | 162 ± 6 | 164 ± 7 | 161 ± 6 | 163 ± 6 |
| Weight (kg) | 67 ± 11 | 69 ± 13 | 71 ± 13 | 70 ± 14 |
| Age at menarche (years) | 14 ± 2 | 14 ± 2 | 14 ± 2 | 14 ± 1 |
| Menopause, n (%) | 229 (89) | 137 ± 80 | 148 ± 82 | 89 ± 75 |
| Age at menopause (years) | 49 ± 4 | 49 ± 4 | 49 ± 5 | 49 ± 4 |
| Years postmenopausal | 18 ± 11 | 15 ± 12 | 19 ± 10 | 13 ± 11 |
| Estrogen therapy (%) | ||||
| Never | 90 | 66 | 93 | 77 |
| Former/Current | 10 | 35 | 7 | 23 |
| Oral contraceptives (%) | ||||
| Never | 91 | 79 | 89 | 70 |
| Former/Current | 9 | 21 | 11 | 31 |
| Cortico steroid therapy (%) | ||||
| Never | 94 | 88 | 94 | 89 |
| Former/Current | 6 | 12 | 6 | 11 |
| Dizziness/instability (%) | ||||
| No | 81 | 83 | 80 | 90 |
| Every week | 11 | 14 | 16 | 9 |
| Every day | 8 | 2 | 4 | 2 |
| Falling (%) | ||||
| Never | 86 | 85 | 88 | 95 |
| Occasionally | 13 | 13 | 11 | 4 |
| 1–2 falls/month | 2 | 2 | 1 | 1 |
| Weekly basis | 0 | 0 | 0 | 0 |
| Smoking (%) | ||||
| Never | 67 | 57 | 75 | 55 |
| Former | 12 | 19 | 10 | 25 |
| Current | 21 | 24 | 15 | 21 |
| Teetotaller (%) | 50 | 37 | 72 | 46 |
| Alcohol (g/week) | 38 (23–-61) | 38 (15–-62) | 23 (15–-62) | 41 (24–-61) |
| History of disease/medication use (%) | 39 | 42 | 34 | 37 |
| Self-reported disability (%) | 19 | 11 | 15 | 6 |
| Self-reported health (%) | ||||
| Good | 25 | 37 | 24 | 37 |
| Fairly good | 52 | 49 | 55 | 50 |
| Poor | 22 | 15 | 21 | 13 |
| Very poor | 1 | 0 | 0 | 0 |
| Grip strength (kg/cm2) | 0.7 ± 0.3 | 0.7 ± 0.2 | 0.7 ± 0.2 | 0.5 ± 0.2 |
| Balance (seconds) | 112 ± 34 | 123 ± 28 | 120 ± 31 | 136 ± 37 |
| Gait velocity (m/s) | 1.5 ± 0.4 | 1.6 ± 0.5 | 1.4 ± 0.3 | 1.7 ± 0.4 |
Analysis of the women in the same area in 1988/89 and 1998/99.
p<0.05 after Bonferroni correction.
Data are presented as means ± SD or as proportions (%) of valid measurements except for alcohol (g/week), which, due to non-normality, is presented as median with first and third interquartile values.